Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Multiple Sclerosis

Free Subscription Articles published in Can J Neurol Sci Retrieve available abstracts of 12 articles: HTML format Text format

Single Articles

October 2018
1. LAPOINTE E, Moghaddam B, Barclay K, Traboulsee AL, et al
   Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis.
   Can J Neurol Sci. 2018 Oct 2:1-3. doi: 10.1017/cjn.2018.
   PubMed     Text format    
   
   
   September 2018
2. BURTON JM, Traboulsee A
   Nothing Ventured, Nothing Gained? Navigating Disease-Modifying Treatment in Multiple Sclerosis.
   Can J Neurol Sci. 2018;45:487-488.
   PubMed     Text format    
   
   
   
3. MIODUSZEWSKI O, MacLean H, Poulin PA, Smith AM, et al
   Trait Mindfulness and Wellness in Multiple Sclerosis.
   Can J Neurol Sci. 2018;45:580-582.
   PubMed     Text format     Abstract available
   
   
   June 2018
4. FREEDMAN MS, Selchen D, Prat A, Giacomini PS, et al
   Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing.
   Can J Neurol Sci. 2018 Jun 12:1-15. doi: 10.1017/cjn.2018.
   PubMed     Text format     Abstract available
   
   
   May 2018
5. OH J, Gagne-Brosseau MS, Guenette M, Larochelle C, et al
   Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
   Can J Neurol Sci. 2018;45:304-312.
   PubMed     Text format     Abstract available
   
   
   March 2018
6. AL-SAKRAN LH, Marrie RA, Blackburn DF, Knox KB, et al
   Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan.
   Can J Neurol Sci. 2018 Mar 20:1-9. doi: 10.1017/cjn.2017.
   PubMed     Text format     Abstract available
   
   
   December 2017
7. TURCOTTE LA, Marrie RA, Patten SB, Hirdes JP, et al
   Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care.
   Can J Neurol Sci. 2017 Dec 18:1-11. doi: 10.1017/cjn.2017.
   PubMed     Text format     Abstract available
   
   
   July 2017
8. BURKHOLDER DB, Koehler PJ, Boes CJ
   Trigeminal Neuralgia and Multiple Sclerosis: A Historical Perspective.
   Can J Neurol Sci. 2017 Jul 19:1-5. doi: 10.1017/cjn.2017.
   PubMed     Text format     Abstract available
   
   
   
9. WALKER LAS, Marino D, Berard JA, Feinstein A, et al
   Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.
   Can J Neurol Sci. 2017 Jul 7:1-9. doi: 10.1017/cjn.2017.
   PubMed     Text format     Abstract available
   
   
   May 2017
10. SADOVNICK AD, Yee IM, Attwell-Pope K, Keyes G, et al
    Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry.
    Can J Neurol Sci. 2017;44:246-254.
    PubMed     Text format     Abstract available
    
    
    March 2016
11. LAPIERRE Y, O'Connor P, Devonshire V, Freedman MS, et al
    Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
    Can J Neurol Sci. 2016;43:278-83.
    PubMed     Text format     Abstract available
    
    
    January 2016
12. VURAL A, Gocmen R, Kurne AT, Oguz KK, et al
    Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
    Can J Neurol Sci. 2016;43:149-56.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: